Compass Pathways Plc
June 23, 2025 - by Joey Ramson
$CMPS is sliding today and hitting all-time lows after the company’s experimental psilocybin treatment for a form of hard-to-treat depression produced results that fell short of investor expectations. The study found a 3.6-point reduction in symptoms compared to a placebo over six weeks.
